Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 ...

The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...

The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...

A judge overseeing 23andMe’s bankruptcy questioned the implications of a provision in President Donald Trump’s “big beautiful ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

A class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March. Biotech company Regeneron is buying the DNA testing startup's assets for $256 million.

Is this tech company behind CEO's bid for 23andMe genetic data? How Anne Wojcicki's group still could snag 23andMe How Anne ...

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who ...

Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.